β-Hydroxy-β-methylbutyrate (HMB) supplementation and functional outcomes in multi-trauma patients: a study protocol for a pilot randomised clinical trial (BOOST trial)

BACKGROUND: There are no therapies proven to diminish the muscle wasting that occurs in patients after major trauma who are admitted to the intensive care unit (ICU). β-Hydroxy-β-methylbutyrate (HMB) is a nutrition intervention that may attenuate muscle loss and, thereby, improve recovery. The prima...

Descripción completa

Detalles Bibliográficos
Autores principales: Wittholz, Kym, Fetterplace, Kate, Ali Abdelhamid, Yasmine, Presneill, Jeffrey J., Beach, Lisa, Thomson, Benjamin, Read, David, Koopman, René, Deane, Adam M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802472/
https://www.ncbi.nlm.nih.gov/pubmed/35101139
http://dx.doi.org/10.1186/s40814-022-00990-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802472/
https://www.ncbi.nlm.nih.gov/pubmed/35101139
http://dx.doi.org/10.1186/s40814-022-00990-9

Ejemplares similares